MakroCare, an international clinical services firm providing clinical research services and Qualitix Clinical Research Inc, a Taiwan CRO headquartered in Taipei, announced the signing of an alliance agreement to offer clinical research services in Taiwan, China and Japan.

Through the alliance, MakroCare - which has its current area of operations in USA, Europe and India - will expand its operations in Asia with a wide range of clinical research services.

MakroCare and Qualitix both operate in key strategic regions of Asia and the relationship between the two companies now means that MakroCare can support clients that need services in Taiwan and China utilizing Qualitix's high quality resources and local know-how, comments the MakroCare officials.

MakroCare, a global clinical services firm provides clinical research support to pharmaceutical, biotechnology, and medical device industries. The company, a knowledge and technology-driven Clinical Research Organization (CRO) providing functional services to the pharmaceutical, biotechnology and medical device industries, offers its services in areas of drug development, functional services, consulting and informatics.

Qualitix Clinical Research Co, Ltd is a full service CRO based in Taiwan with office in China and focuses on clinical monitoring and site management services for multinational phase-II and phase-III studies.